-+ 0.00%
-+ 0.00%
-+ 0.00%

MIRUM PHARMACEUTICALS - PLANS SNDA SUBMISSION IN H1 2027 TO EXPAND ATEBRIOZ INDICATION TO AGES 6 TO <12

Reuters·10/26/2026 12:00:02

Please log in to view news